Autoimmune And Rheumatic Diseases
‘Strong leaders’ seek to collaborate, can improve care for rheumatology patients
Leaders who are willing to collaborate with both patients and other health care professionals are more likely to achieve optimal disease outcomes, according to experts who participated in a panel discussion.
‘Accountability is a love language’ both inside and outside the clinic
Holding others accountable and being held accountable for transgressions of all types can lead to growth in relationships, according to the keynote presenter at the 2024 Association of Women in Rheumatology annual conference.
Training the ‘inner voice to be kind’ critical for young patients with rheumatic diseases
ORLANDO, Fla. — Cognitive behavioral therapy can help children and adolescents with rheumatic diseases cope with the challenges of their condition, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
‘We try not to limit them’: Striving for normalcy key for children with rheumatic diseases
ORLANDO, Fla. — Allowing children with rheumatic diseases the time and space to formulate their own thoughts on their condition can facilitate communication and help them live a normal life, according to a presenter.
World Sjögren’s Day shines light on a disease that too often goes years without diagnosis
Despite being the second-most common rheumatic autoimmune disease in the United States, Sjögren’s syndrome remains under-recognized, with patients often waiting 3 years for a proper diagnosis, according to the Sjögren’s Foundation.
VIDEO: CAR T-cell therapy ‘holding up as a possible breakthrough’ in autoimmune disease
In this video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, calls out top stories in the July issue, including a cover story on chimeric antigen receptor T-cell therapy.
Minimizing distrust, explaining process essential to increasing trial participation
ORLANDO, Fla. — Explaining the details of the clinical trial process is critical to minimizing barriers to research participation, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
‘A lot of unknowns’: Much remains a mystery regarding sarcoidosis etiology, management
ORLANDO, Fla. — Despite a constellation of available data points regarding prognosis and impacted organs, researchers have so far been unable to connect the dots and form a better understanding of sarcoidosis, according to a presenter here.
‘Silver tsunami’ likely to have significant impacts for rheumatology providers
ORLANDO, Fla. — The aging process can cause a significant decline in the immune system, a process set to impact a growing proportion of the general population and rheumatic patients alike, according to a presenter here.
Monitoring nightmares, hallucinations ‘extremely valuable’ in lupus, early flare treatment
Nightmares and hallucinations may occur at any stage of disease course in patients with systemic lupus erythematosus, according to recent findings.